Document is current
Any future updates will be listed below
-
Authors
Simpson, C. R.
Shi, T. http://orcid.org/0000-0002-4101-4535
Vasileiou, E.
Katikireddi, S. V. http://orcid.org/0000-0001-6593-9092
Kerr, S.
Moore, E.
McCowan, C.
Agrawal, U.
Shah, S. A. http://orcid.org/0000-0001-5672-0443
Ritchie, L. D.
Murray, J.
Pan, J.
Bradley, D. T. http://orcid.org/0000-0003-1468-1823
Stock, S. J. http://orcid.org/0000-0003-4308-856X
Wood, R.
Chuter, A.
Beggs, J.
Stagg, H. R.
Joy, M.
Tsang, R. S. M. http://orcid.org/0000-0002-2520-526X
de Lusignan, S. http://orcid.org/0000-0002-8553-2641
Hobbs, R.
Lyons, R. A.
Torabi, F. http://orcid.org/0000-0002-5853-4625
Bedston, S.
O’Leary, M.
Akbari, A. http://orcid.org/0000-0003-0814-0801
McMenamin, J.
Robertson, C.
Sheikh, A. http://orcid.org/0000-0001-7022-3056
-
Funding
Funding for this research was provided by:
DH | National Institute for Health Research
- License Information
-
More Information
Article History
Received: 4 May 2021
Accepted: 26 May 2021
First Online: 9 June 2021
Competing interests
: A.S. is a member of the Scottish Government Chief Medical Officer’s COVID-19 Advisory Group and the New and Emerging Respiratory Virus Threats Risk Stratification Subgroup and AstraZeneca’s COVID-19 Thrombocytopenia Task Force; all roles are remunerated to A.S. or his institution. C.R.S. declares funding from the Medical Research Council, the National Institute for Health Research, the Chief Scientist Office and the New Zealand Ministry for Business, Innovation and Employment and Health Research Council during the conduct of this study. S.V.K. is co-chair of the Scottish Government’s Expert Reference Group on COVID-19 and Ethnicity, is a member of the Scientific Advisory Group on Emergencies subgroup on ethnicity and acknowledges funding from an NHS Research Scotland Senior Clinical Fellowship, the Medical Research Council and the Chief Scientist Office. C.R. is a member of the Scottish Government Chief Medical Officer’s COVID-19 Advisory Group, the Scientific Pandemic Influenza Group on Modelling and the Medicines & Healthcare products Regulatory Agency’s Vaccine Benefit and Risk Working Group. H.R.S. is an advisor to the Scottish Parliament’s COVID-19 Committee. All other authors report no financial conflicts of interest.
